withanolides – Ayurved Healing

Gallic Acid to Withanolides: Phytochemical Profiles of 8 Key Herbs

Dr. Meera Iyer — Tue, 01 Sep 2026 09:00:00 +0000

Reading Herb Labels Without the Chemistry Degree

The supplement market now places a “standardized to X% active compound” claim on many Ayurvedic herb products, but that number is only useful when the marker compound, plant part, extraction method, and intended use all make sense together. A high percentage is not automatically better. A label that says “5% withanolides,” “20% bacosides,” or “95% curcuminoids” tells only part of the story; it does not tell whether the correct plant part was used, whether the marker reflects the herb’s traditional activity, or whether the dose matches the preparation.

Ayurvedic herb phytochemistry helps consumers and practitioners read labels more intelligently. It does not replace the Ayurvedic assessment of the whole dravya, its part used, preparation, dose, anupana, season, constitution, digestion, and clinical context. A churna, decoction, ghrita, arishta, fresh juice, resin extract, or modern capsule may each emphasize different compound groups. The goal is not to reduce Ayurveda to chemistry, but to use chemistry as a quality-control lens.

1. Ashwagandha (Withania somnifera): Withanolides

Key compounds: withanolides such as withaferin A, withanolide A, withanolide D, withanone, withanosides, and alkaloids. For classical and pharmacopoeial identity, the root is the primary part to check on a label, not an unspecified “whole plant” extract.

Withanolides are useful marker compounds for ashwagandha, but the label should not be read as “more withanolides equals better ashwagandha.” Root extracts used for stress, sleep, and vitality are typically evaluated as whole extracts with a defined withanolide content. Extracts that include leaf material can have a different withanolide profile, especially with respect to withaferin A. A good label should specify Withania somnifera, the plant part, the extract ratio or dose, the assay method if available, and the total withanolide percentage.

Practical benchmark: root-only extracts standardized around 5% withanolides are common in well-documented stress and sleep products. A product with 10% or higher total withanolides is not automatically superior unless the dose, plant part, and withaferin A profile are also clear. For everyday rasayana-style use, traditional root powder remains a valid format when identity, purity, and dose are reliable.

2. Amla / Amalaki (Emblica officinalis / Phyllanthus emblica): Tannins, Gallic Acid, Ellagic Acid, and Vitamin C

Key compounds: hydrolysable tannins including emblicanin A and B, punigluconin, pedunculagin, gallic acid, ellagic acid, corilagin, chebulagic acid, and ascorbic acid. The Ayurvedic Pharmacopoeia identifies Amalaki as the fruit/pericarp of Emblica officinalis, synonym Phyllanthus emblica.

Amla is often marketed as a vitamin C source, but its value is not limited to vitamin C. Its tannins and polyphenols help distinguish it from products that merely add ascorbic acid. Gallic acid and ellagic acid are useful analytical markers, but they are not unique to amla; many tannin-rich herbs contain them. Therefore, a label that only says “standardized to gallic acid” is less informative than a label that identifies amla fruit, total tannins or polyphenols, and marker compounds such as gallic acid and ellagic acid.

Practical benchmark: prefer products that specify authentic amla fruit/pericarp, avoid vague “vitamin C complex” claims without fruit identity, and use multi-marker testing where possible. “Emblicanin A+B” may be useful when the testing method is disclosed, but it should not be treated as a universal minimum standard for every amla product.

3. Bacopa monnieri (Brahmi): Bacosides

Key compounds: dammarane-type triterpenoid saponins known as bacosides and bacopasides. “Bacoside A” is not a single molecule; it is a mixture that includes compounds such as bacoside A3, bacopaside II, bacopaside X, bacopasaponin C, and related jujubogenin-type saponins.

Bacopa labels can be confusing because “bacosides” may refer to a broad saponin class, a calculated total, or a specific analytical grouping. This makes the testing method important. A product standardized to 20% bacosides and a product standardized to 55% bacosides may not be directly comparable unless the assay method, extract dose, and clinical protocol are also known.

Practical benchmark: for cognitive-support products, many published human protocols use 300–450 mg/day of standardized bacopa extract, often around 45–55% bacosides, over several weeks. Lower-percentage extracts are not automatically inferior if the total delivered bacoside dose and method are transparent. A good bacopa label should specify Bacopa monnieri, the whole plant or aerial part used, percentage of bacosides, and ideally HPLC-based marker testing.

4. Turmeric / Haridra (Curcuma longa): Curcuminoids and Turmerones

Key compounds: curcuminoids, especially curcumin, demethoxycurcumin, and bisdemethoxycurcumin, along with volatile oil constituents such as turmerones. Curcuminoids give turmeric its yellow-orange pigment, while volatile oils belong to a different chemical fraction of the rhizome.

Curcumin is poorly absorbed when taken as a plain isolated compound. This is why labels on modern turmeric supplements often mention piperine, phospholipid complexes, micelles, nanoparticles, essential oil combinations, or other delivery systems. A product standardized to 95% curcuminoids can still vary greatly in delivered effect depending on the formulation and dose.

Practical benchmark: for concentrated supplements, look for the actual milligrams of curcuminoids per serving, not only the extract weight. Also check whether the product uses piperine or another delivery system, because piperine can increase absorption but may also affect medication metabolism. For culinary and traditional Ayurvedic use, whole turmeric rhizome or powder with fat and appropriate spices remains a different and legitimate format, not a “weaker” version of a capsule.

Herb	Primary Label Markers	What to Check	Better Label Benchmark	Use Caution With
Ashwagandha (Withania somnifera)	Withanolides, withaferin A, withanosides	Root vs leaf/root extract, total withanolides, withaferin A profile	Root extract with declared withanolide percentage and clear dose	Pregnancy, liver disease, autoimmune conditions, sedatives, thyroid medicines
Amla / Amalaki (Emblica officinalis)	Tannins, emblicanins, gallic acid, ellagic acid, vitamin C	Fruit/pericarp identity, tannin profile, added ascorbic acid	Authentic fruit extract with multi-marker polyphenol or tannin testing	Anticoagulant, antiplatelet, or diabetes medicines
Brahmi (Bacopa monnieri)	Bacosides, bacopasides, bacoside A mixture	Assay method, total bacosides, daily extract dose	Standardized extract with bacoside percentage and dose matched to intended use	Thyroid medicines, anticholinergic or cholinergic medicines, bradycardia-prone patients
Turmeric / Haridra (Curcuma longa)	Curcuminoids, curcumin, demethoxycurcumin, turmerones	Curcuminoid milligrams, delivery system, piperine content	Declared curcuminoids plus absorption strategy, or whole rhizome for food/traditional use	Anticoagulants, antiplatelets, gallbladder disease, medicines affected by piperine
Triphala	Gallic acid, ellagic acid, chebulinic acid, chebulagic acid, tannins	Authentic three-fruit composition and fruit ratio	Amalaki, Haritaki, and Bibhitaki identity with tannin/polyphenol markers	Loose stools, dehydration risk, concurrent laxatives
Boswellia / Shallaki (Boswellia serrata)	Boswellic acids, AKBA, KBA, beta-boswellic acid	Total boswellic acids versus AKBA-enriched extract	Declared AKBA level or full boswellic acid profile	Anticoagulant or antiplatelet medicines; monitor with anti-inflammatory drugs
Shatavari (Asparagus racemosus)	Steroidal saponins, shatavarins, shatavarin IV	Root identity, total saponins, shatavarin marker testing	Root extract with declared saponin or shatavarin IV marker	Pregnancy, lactation concerns, hormone-sensitive conditions, diuretic medicines
Guduchi / Giloy (Tinospora cordifolia)	Tinosporide, tinosporaside, alkaloids, diterpenoid lactones, polysaccharides	Correct species, stem identity, extract type, contamination and substitution testing	Authenticated T. cordifolia stem with pharmacopoeial quality controls	Liver disease, autoimmune disease, immunosuppressant medicines

5. Boswellia / Shallaki (Boswellia serrata): AKBA and Boswellic Acids

Key compounds: acetyl-11-keto-beta-boswellic acid (AKBA), 11-keto-beta-boswellic acid (KBA), alpha-boswellic acid, beta-boswellic acid, acetyl-alpha-boswellic acid, and acetyl-beta-boswellic acid.

Boswellia is a good example of why “total extract” and “active fraction” are not the same thing. Traditional resin preparations contain a mixture of boswellic acids, while modern joint-support extracts may enrich AKBA or improve delivery of boswellic acid fractions. A label stating “65% boswellic acids” is not equivalent to a label stating “30% AKBA,” because these refer to different analytical targets.

Practical benchmark: for joint-focused boswellia products, look for either a declared AKBA percentage or a clear boswellic acid profile. High-AKBA extracts have been used at much lower capsule weights than ordinary resin powders, so the milligram dose should be interpreted together with the AKBA content. For traditional Ayurvedic use, resin identity, purity, and correct formulation remain essential.

6. Shatavari (Asparagus racemosus): Steroidal Saponins

Key compounds: steroidal saponins known as shatavarins, especially shatavarin I–IV, along with flavonoids, polysaccharides, and related root constituents.

Shatavari labels often mention “saponins,” but total saponin percentage alone is a broad marker. The more informative label identifies Asparagus racemosus root and gives either total saponins with a method or a more specific marker such as shatavarin IV. This is especially important because related Asparagus species can differ chemically.

Practical benchmark: do not treat “10–15% saponins” as a universal requirement for all shatavari products. It is better to check species, root identity, extract ratio, total saponins, shatavarin marker testing where available, and intended use. Classical powder, granules, ghrita, and modern extracts can each have a different place depending on the person and indication.

7. Guduchi / Giloy (Tinospora cordifolia): Species Identity Matters More Than a Single Marker

Key compounds: diterpenoid lactones such as tinosporide, alkaloids including berberine and related compounds, glycosides, steroids, phenolics, and polysaccharides. The Ayurvedic Pharmacopoeia identifies Guduchi as dried mature stem pieces of Tinospora cordifolia.

Guduchi is often marketed as an “immune” herb, but quality control begins with correct species and plant part. A berberine-only label is not a sufficient way to judge Guduchi quality, because berberine is not unique to Guduchi and does not represent the full stem profile. Authentication is especially important because Tinospora species and commercial preparations can vary.

Practical benchmark: choose products that specify Tinospora cordifolia stem, use pharmacopoeial identity and purity checks, and provide sensible extract information rather than relying on a single alkaloid marker. People with liver disease, autoimmune conditions, or those using immunosuppressant medicines should use Guduchi only with qualified supervision.

8. Triphala: Formula Identity Before Marker Percentages

Key compounds: tannins and polyphenols such as gallic acid, ellagic acid, chebulinic acid, and chebulagic acid from the three fruits Amalaki, Haritaki, and Bibhitaki.

Triphala is not a single herb extract, so the first quality question is whether the formula contains the correct three fruits in the intended ratio. Gallic acid and ellagic acid are useful analytical markers, but they cannot prove full formula quality by themselves. A product could contain tannins and still fail to represent the intended Triphala composition.

Practical benchmark: look for declared botanical identity of all three fruits, batch testing for microbial and heavy-metal safety, and a marker profile that includes tannins or polyphenols. For digestive use, dose and bowel tolerance matter more than chasing a high tannin percentage.

Implications for Purchasing Decisions

Three practical rules make herb labels easier to read.

First, identify the plant part. Ashwagandha root, Bacopa whole plant or aerial parts, Guduchi stem, Shatavari root, turmeric rhizome, Boswellia resin, and amla fruit/pericarp are not interchangeable with vague “whole herb” language. Plant part often changes the compound profile more than the standardization percentage does.

Second, identify whether the marker compound is meaningful for that herb. Withanolides are useful for ashwagandha, bacosides for bacopa, curcuminoids for turmeric extracts, AKBA or boswellic acids for boswellia, shatavarins for shatavari, and tannin/polyphenol profiles for amla and Triphala. A single generic marker such as gallic acid or berberine should not be overvalued when it does not represent the full herb.

Third, match the format to the intended use. Aqueous decoctions emphasize water-soluble constituents, alcohol extracts emphasize different phytochemicals, resin extracts require attention to acid fractions, and fat-based preparations can carry lipophilic compounds. Classical Ayurvedic dosage forms and modern standardized extracts answer different quality questions; one is not automatically superior to the other.

Disclaimer: This article is for educational purposes only and does not replace professional medical advice. Consult a qualified Ayurvedic practitioner or healthcare provider before starting any new herb, extract, or supplement, especially if you are pregnant, nursing, have liver, thyroid, autoimmune, bleeding, or chronic medical conditions, or take prescription medicines.

References

Withania somnifera Root vs Leaf Extracts: What Clinical Trials Reveal About Different Plant Parts

Dr. Meera Iyer — Mon, 27 Jul 2026 10:30:00 +0000

The Plant Part Problem in Ashwagandha Supplementation

Ashwagandha (Withania somnifera) products are not all the same. A capsule may contain root powder, root extract, whole-plant material, a root-and-leaf extract, or an extract whose plant part is not clearly stated. This distinction matters because the root and leaf have different identities in traditional use and different phytochemical profiles in modern analysis.

For classical internal rasayana use, the root is the standard reference point. The Ayurvedic Pharmacopoeia of India defines Asvagandha as the dried mature root of Withania somnifera Dunal and gives its pharmacological profile for that root drug. Leaf material may have its own uses and chemistry, but an unspecified “ashwagandha extract” label should not automatically be assumed to mean the same thing as traditional ashwagandha root.

Classical and Pharmacopoeial Position

The pharmacopoeial Ayurvedic identity of Asvagandha is rooted in the moola, the mature dried root. In that form, it is described with the following Ayurvedic properties and actions:

Ayurvedic Category	Ashwagandha Root Profile	Practical Meaning
Botanical identity	Dried mature root of Withania somnifera Dunal	The pharmacopoeial drug is the root, not an unspecified aerial-part extract.
Rasa	Tikta, Kashaya	Bitter and astringent taste profile.
Guna	Laghu	Light quality as listed in the pharmacopoeial monograph.
Virya	Ushna	Heating potency.
Vipaka	Madhura	Sweet post-digestive effect.
Karma	Rasayana, Vatakaphapaha, Balya, Vajikarana	Rejuvenative, Vata-Kapha pacifying, strength-promoting, and reproductive-vitality supporting actions.
Therapeutic uses listed	Shotha, Kshaya, Daurbalya, Vataroga, Klaibya	Traditionally directed toward swelling, wasting, debility, Vata disorders, and sexual debility under appropriate guidance.
Root powder dose	3–6 g	Traditional powder dosing should be individualized by a qualified practitioner.

Phytochemical Differences: Root vs Leaf

Ashwagandha contains alkaloids, steroidal lactones, saponins, and withanolides. Root and leaf material can share some compounds, but they do not present the same chemical pattern. This is why total withanolide percentage alone is not a complete measure of quality for traditional internal use.

Quality Question	Root	Leaf or Root-and-Leaf Material	Practical Meaning
Classical internal identity	The Ayurvedic pharmacopoeial drug is the mature dried root.	Leaf material is not the pharmacopoeial identity of Asvagandha root.	For rasayana, balya, and vajikarana use, root is the traditional default.
Withanolide pattern	Root analyses show a distinct marker profile, including root-enriched withanolides in some chemotypes.	Leaf analyses show a different pattern, often with higher concentration of several withanolides.	A higher total withanolide number does not automatically mean a better root-equivalent product.
Withaferin A	Detected in root samples, but not necessarily the dominant marker.	A prominent pharmacologically active withanolide in aerial-part chemistry and preclinical literature.	Withaferin A is not a stand-alone marker for classical rasayana quality.
Named extracts	Some named extracts are root-only and should be assessed as such.	Some named extracts are root-and-leaf preparations and should be assessed as their own formulations.	The label should be matched to the exact plant part and extract used in published human trials.
Consumer label risk	“Root extract” gives a clearer match to traditional internal use.	“Ashwagandha extract” without plant part leaves room for ambiguity.	Plant part disclosure is essential for informed selection.

Human Trial Record by Plant Part

The human trial record for stress, sleep, and resistance-training outcomes is concentrated around specific root extracts and specific proprietary root-and-leaf extracts. These should not be treated as interchangeable unless the plant part, dose, standardization, and preparation are clearly matched.

Root Extracts for Stress, Sleep, and Strength

Several widely cited human trials used ashwagandha root extract. A 60-day randomized trial in adults with chronic stress used a high-concentration full-spectrum root extract at 300 mg twice daily. An insomnia trial used ashwagandha root extract at 300 mg twice daily for 10 weeks. A resistance-training trial in healthy young men used root extract at 300 mg twice daily for 8 weeks and reported improvements in strength and body-composition measures alongside training.

Root-and-Leaf Extracts

Some proprietary extracts used in human trials are root-and-leaf preparations rather than root-only preparations. These may have their own clinical profile, but they should be understood as specific standardized formulations, not as proof that any unspecified leaf-heavy or whole-plant extract is equivalent to traditional ashwagandha root.

Pure Leaf Extracts

Leaf material has meaningful chemistry and has been associated in traditional and ethnobotanical sources with external uses such as pastes for local swelling, boils, wounds, and skin conditions. That is different from using the root internally as a rasayana. For routine internal supplementation aimed at stress support, sleep support, strength, general debility, or reproductive vitality, leaf-only extracts should not be assumed to be interchangeable with root powder or root extract.

Safety Considerations

Ashwagandha is widely used, but it is not suitable for everyone. Safety depends on the person, the preparation, dose, duration, medical history, and medications. Plant part disclosure helps selection, but it does not remove the need for clinical judgment.

Liver safety: Rare cases of clinically apparent liver injury have been reported with ashwagandha-containing supplements. People with liver disease, cirrhosis, or unexplained liver-test abnormalities should avoid self-prescribing it. Stop use and seek medical care if jaundice, dark urine, intense itching, abdominal pain, unusual fatigue, or persistent nausea develops.
Thyroid and autoimmune conditions: People with thyroid disorders, autoimmune disease, or hormone-sensitive prostate cancer should use ashwagandha only with professional supervision.
Medication interactions: Caution is needed with thyroid hormone, sedatives, anti-seizure medicines, diabetes medicines, blood-pressure medicines, and immunosuppressants.
Pregnancy, breastfeeding, and surgery: Ashwagandha should be avoided during pregnancy and breastfeeding. It should also be stopped before surgery unless the treating clinician advises otherwise.
Drowsiness and digestion: Some people may experience drowsiness, stomach upset, diarrhea, or vomiting. Dose and timing should be individualized.
Duration: Short-term use is better characterized than long-term continuous use. Periodic review by a qualified practitioner is advisable, especially for daily supplementation.

Practical Guidance: Choosing the Right Extract

The practical choice should begin with the intended use. For classical Ayurvedic internal use, root remains the most appropriate default. Root-and-leaf extracts may be appropriate only when the product is a clearly defined standardized preparation and the user understands that it is not the same as root-only ashwagandha.

Goal	Best-Matched Form	Commonly Used Range	Important Note
Classical rasayana and general debility support	Ashwagandha root powder or root-based formulation	3–6 g root powder in pharmacopoeial guidance	Use with suitable anupana and practitioner guidance.
Stress support	Clearly labeled root extract or a clearly identified standardized root-and-leaf extract	Human trials commonly use hundreds of milligrams per day of standardized extract	Do not substitute an unspecified extract for a studied preparation.
Sleep support	Root extract is the closest match to the root-based insomnia trial record	One trial used 300 mg twice daily for 10 weeks	Avoid combining with sedatives unless supervised.
Resistance training and strength support	Root extract	One resistance-training trial used 300 mg twice daily for 8 weeks	Benefits were assessed alongside structured training.
External local applications	Traditional paste or topical preparation under practitioner guidance	Not the same as internal supplement dosing	Leaf or leaf-root topical use should not be converted into an oral supplement assumption.

How to Verify What You Are Getting

A good ashwagandha label should tell you what part of the plant is used and how the extract is standardized. Without that information, the product cannot be confidently matched to classical Ayurvedic use or to a specific human trial record.

Look for the plant part. Prefer labels that clearly say “root powder,” “root extract,” “root and leaf extract,” or “whole plant.” Avoid products that say only “ashwagandha extract” without plant-part disclosure.
Do not judge by withanolide percentage alone. A high withanolide percentage may reflect a different plant-part profile rather than a stronger version of traditional root ashwagandha.
Ask for a Certificate of Analysis. A useful CoA should address identity, plant part, marker profile, heavy metals, pesticides, microbial limits, and adulterants.
Match named extracts correctly. Root-only extracts and root-and-leaf extracts should be evaluated as different preparations, even when both are sold under the broad name “ashwagandha.”
Use caution with medical conditions. Anyone with liver disease, thyroid disease, autoimmune disease, pregnancy, breastfeeding, planned surgery, or regular medication use should consult a qualified healthcare provider before use.

The Ayurvedic Perspective: Why the Part Used Matters

The Ayurvedic preference for the root in internal rasayana use is not a minor labeling detail. It is part of the identity of the drug. The root is the pharmacopoeial Asvagandha used for rasayana, balya, vajikarana, and Vata-Kapha pacifying purposes. Leaf material and root-and-leaf extracts may have their own applications, but they should not be silently substituted for root when the goal is classical internal ashwagandha therapy.

This plant-part distinction is a practical example of why traditional identity and modern quality control must work together. For more on how classical observation can guide modern validation, see Reverse Pharmacology in Ayurveda. For understanding how the carrier substance affects herb use, see The Science of Anupana.

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Ashwagandha should be used under the guidance of a qualified Ayurvedic practitioner or healthcare provider, especially if you are pregnant, breastfeeding, taking medication, preparing for surgery, or living with liver disease, thyroid disease, autoimmune disease, hormone-sensitive prostate cancer, diabetes, high blood pressure, anxiety, insomnia, or any chronic medical condition.

References

Phytochemical Profiling of Ashwagandha: Withanolides, Alkaloids, and What Each Does

Dr. Meera Iyer — Tue, 26 May 2026 09:00:00 +0000

When a supplement company markets ashwagandha as “standardized to 5% withanolides,” it is making a claim about phytochemical content. But do they know — and do you know — what that 5% actually contains, which withanolide is most bioactive, and whether the preparation method preserves that compound’s stability? The ashwagandha supplement market generates over $500 million annually, and most of it is sold on the strength of a single word — “withanolides” — that most consumers, and frankly many formulators, cannot precisely define.

As a pharmacognosist, I find this gap between commercial claims and chemical reality worth closing. Ashwagandha (Withania somnifera) is one of the most pharmacologically complex herbs in the Ayurvedic pharmacopoeia. Its effects are not attributable to a single compound but to a constellation of at least 40 withanolides, around a dozen alkaloids, and numerous other constituents that act through different molecular pathways. Understanding what each does lets you choose preparations that match your actual therapeutic goal.

The Withanolide Family: Not a Single Compound

Withanolides are steroidal lactones largely characteristic of the Solanaceae family, with notably high concentrations in Withania somnifera. Over 40 have been isolated and characterized from the plant. They are not equivalent — their biological activities differ markedly with structural features such as the position and degree of hydroxylation, the orientation of the lactone ring, and the presence of specific functional groups.

Withaferin A (WFA)

Withaferin A is the most studied and arguably most pharmacologically potent individual withanolide. Its reactive structural features — a 4beta-hydroxy group and an epoxide function — let it engage several cellular targets:

NF-kB inhibition: WFA inhibits the Nuclear Factor-kappa B pathway by direct alkylation of the IKK-beta subunit, blocking inflammatory gene transcription. This mechanism explains much of ashwagandha’s anti-inflammatory activity and was established by Kaileh and colleagues (Journal of Biological Chemistry, 2007), who showed that WFA hyperphosphorylates IKK-beta while potently inhibiting its catalytic activity.
Hsp90 inhibition: In cell studies WFA binds heat shock protein 90 (Hsp90) at a site distinct from conventional Hsp90 inhibitor drugs, disrupting the chaperone activity that many cancer-cell proteins depend on. This underlies research into WFA as an adjunct in oncology support.
Vimentin targeting: WFA covalently targets vimentin, an intermediate filament protein involved in cell motility and tumour invasion, which contributes to the antimetastatic activity observed in cell studies.
Telomerase inhibition: Contrary to a common misconception, WFA inhibits telomerase activity and suppresses hTERT expression in cancer cell lines — consistent with its antiproliferative, pro-apoptotic profile rather than any pro-longevity “telomerase activation.”

Key point for supplementation: WFA is generally present in higher concentrations in root-plus-leaf preparations than in root-only preparations. It is also heat-labile — hot-water extraction can degrade it significantly. This is one reason traditional milk-based preparations (Ashwagandha ksheerapaka) can show a different withanolide profile from standardized ethanol extracts.

Withanolide A and B

Withanolide A and Withanolide B are the withanolides most associated with ashwagandha’s neurotrophic and cognitive effects, and they are mechanistically distinct from WFA:

Neurite outgrowth promotion: A landmark study by Kuboyama, Tohda and Komatsu (British Journal of Pharmacology, 2005) showed that withanolide A induced regeneration of axons and dendrites and reconstruction of pre- and post-synapses in cultured cortical neurons, with recovery of neuronal function in a model of neuronal damage. The effect reflects genuine neuritic repair, not a single named signalling pathway.
Beta-amyloid clearance: Withania somnifera has been shown to reduce beta-amyloid burden; in one widely cited study (Sehgal et al., PNAS, 2012) it enhanced amyloid clearance by upregulating low-density lipoprotein receptor-related protein (LRP). This is consistent with ashwagandha’s traditional valuation as a Rasayana (rejuvenative) with Medhya (mind-supporting) action.
GABAergic modulation: Withanolide A modulates GABA-A receptor activity, contributing to anxiolytic effects distinct from the hypothalamic-pituitary-adrenal (HPA) axis modulation of other constituents.

12-Deoxywithastramonolide and Withastramonolide

These less-publicized withanolides add to the overall anti-inflammatory activity of whole-herb preparations, complementing WFA’s NF-kB / IKK-beta inhibition rather than duplicating it. The breadth of the constituent mixture is part of why whole-herb ashwagandha can behave differently from isolated WFA in trials measuring anti-inflammatory outcomes — the activity is distributed across several molecules rather than concentrated in one.

The Alkaloid Profile: Somniferine, Anaferine, and Others

Alkaloids are a chemically diverse, pharmacologically active group of nitrogen-containing compounds in ashwagandha. They receive less commercial attention than withanolides but contribute meaningfully to the herb’s clinical character.

Somniferine

The species epithet somnifera is Latin — somnus (sleep) and ferre (to bear), literally “sleep-bearing” — applied to the plant for its long-recognised sedative use. The alkaloid somniferine was in turn named after the species, not the other way around. Early research described sedative properties and reported activity on cholinergic pathways in the central nervous system. This profile is traditionally linked to:

Ashwagandha’s sleep-supporting effect at evening doses
Support of memory consolidation (acetylcholine is central to hippocampal learning circuits)
The common clinical preference for evening dosing in many protocols

Withanine and Pseudowithanine

These alkaloids are part of ashwagandha’s broader constituent profile and contribute to its adaptogenic character. The herb’s best-documented endocrine effect — cortisol reduction — is a property of the whole standardized root extract rather than any single isolated alkaloid. In a 2012 double-blind, randomized controlled trial (Chandrasekhar et al., Indian Journal of Psychological Medicine), 300 mg of a standardized full-spectrum root extract twice daily significantly reduced serum cortisol versus placebo — one of the better-powered clinical trials in the ashwagandha literature — working alongside withanolide modulation of the HPA axis.

Anaferine and Tropine

These alkaloids have been associated with mild muscarinic and pro-kinetic (gut-motility) activity. That fits the classical Ayurvedic practice of pairing Ashwagandha with digestive formulas where Vata-related dryness, constipation, or gas accompanies debility — using the herb’s nourishing action while supporting Agni and the downward movement of Vata.

Brimhana and Balya: Strength and Tissue-Building Properties

Beyond its modern phytochemistry, Ashwagandha is classically a Balya (strength-giving) and Brimhana (nourishing, anabolic) Rasayana. Charaka and later authors employ it for Karshya (emaciation), Kshaya (depletion or wasting), and convalescence — to rebuild Mamsa (muscle) and Shukra (reproductive tissue) and to restore Bala (strength) in those weakened by chronic illness, overwork, or age. This anabolic, tonic role — rather than any direct mineral or hematinic effect — is the authentic classical basis for its use in building body mass and stamina, and it is why the herb is traditionally given in warm milk (ksheerapaka) for Brimhana purposes.

How Different Preparations Affect Phytochemical Content

The same root yields very different phytochemical profiles depending on how it is processed. Extraction solvent, heat exposure, and traditional samskara (processing) each shift which withanolides and alkaloids survive and in what proportion. The table below summarises how common preparations compare and where each is best suited.

Preparation Type	Withanolide Content	Alkaloid Preservation	Best Clinical Use
Whole root powder	Moderate (0.1-0.5% total)	Excellent – all alkaloids intact	Traditional daily tonic; general adaptation
KSM-66 (root-only ethanol extract)	Standardized to ~5% withanolides	Good – alkaloids present	Stress, cortisol, cognitive function
Sensoril (root+leaf aqueous extract)	Standardized to ~10% withanolides; higher WFA	Moderate	Higher anti-inflammatory activity; oncology-support research
Traditional milk decoction (Ksheerapaka)	Lower (milk solubility limits extraction)	Good	Sleep, muscle building, weight gain (Brimhana use)
Ashwagandharishta (fermented preparation)	Moderate, transformed by fermentation	Good to excellent	Long-term adult tonic; nervous-system support; convalescent debility (fermented, ~5-10% alcohol – not for children or in pregnancy)

The Cortisol-Ashwagandha Mechanism in Detail

HPA-axis regulation is ashwagandha’s best-documented mechanism in the clinical literature and worth examining at the molecular level. Cortisol secretion is governed by a feedback loop: the hypothalamus secretes CRH (corticotropin-releasing hormone), which stimulates the pituitary to secrete ACTH, which stimulates adrenal cortisol production. Chronically elevated cortisol develops when this loop becomes poorly regulated (HPA-axis dysregulation).

Withanolides appear to interact with this system at multiple points:

Reducing CRH secretion through hippocampal glucocorticoid-receptor sensitization
Modulating adrenal-cortex responsiveness to ACTH
Supporting a healthier DHEA-to-cortisol balance

The clinical result is not cortisol suppression (which would be problematic) but cortisol normalization — restoring the circadian rhythm of cortisol that chronic stress disrupts. Morning cortisol rises appropriately, while evening cortisol falls as it should. This is why ashwagandha can support both energy (morning cortisol appropriate for wakefulness) and sleep (evening cortisol reduced as needed for sleep initiation).

Dosage-Compound Relationship

Matching the preparation to the target compound makes dosing more rational than a generic “take ashwagandha” instruction. The table below pairs common clinical goals with the constituents most associated with them and an evidence-informed dose range. These are general guidelines, not prescriptions, and should be individualised with a qualified practitioner.

Clinical Goal	Target Compound	Recommended Form	Evidence-Based Dose
Cortisol reduction/stress	Withanolides, withanine alkaloids	KSM-66 or Sensoril extract	300-600mg twice daily
Cognitive enhancement	Withanolide A and B, somniferine	KSM-66; traditional powder at night	300mg KSM-66 or 3-5g powder at night
Anti-inflammatory	WFA, 12-deoxywithastramonolide	Sensoril (higher WFA content)	250mg twice daily
Muscle and strength	Withanolides; Brimhana/Balya action	Root powder in milk	5g root powder in warm milk nightly
Sleep quality	Somniferine (cholinergic); Withanolide A (GABAergic)	Whole root powder in warm milk	3-5g powder (or 300-600mg extract) at bedtime

Stability, Bioavailability, and Absorption

Withanolides are fat-soluble steroidal lactones, and their absorption increases when they are taken with fat — which is precisely why the classical Ashwagandha ksheerapaka (milk preparation with ghee) is pharmacologically sophisticated rather than merely traditional. Full-fat milk and ghee together provide a favourable lipid matrix for withanolide absorption.

Piperine (from Maricha, black pepper) is a recognised bioavailability enhancer for fat-soluble plant compounds, which is consistent with the classical use of a little Trikatu (ginger, black pepper, long pepper) alongside tonic formulations as an anupana. In that light the pairing is a deliberate pharmaceutical choice, not only a matter of taste.

For related reading on how different standardized extracts compare clinically, see our post on KSM-66 vs Sensoril: Which Ashwagandha Extract Is Backed by Better Evidence. For the broader context of Ayurvedic herb-drug interactions, see Herb-Drug Interactions: A Pharmacologist Safety Guide.

Ashwagandha preparations should be used with caution in pregnancy, autoimmune conditions, thyroid disorders (it may increase thyroid hormone levels), and alongside sedative medications; alcohol-containing arishta forms are inappropriate for children and in pregnancy. Consult a qualified Ayurvedic practitioner or your healthcare provider before starting any therapeutic regimen involving standardized ashwagandha extracts.

Key References

Withaferin A NF-kB / IKK-beta inhibition – Kaileh et al., Journal of Biological Chemistry (2007), PMID 17150968
Withanolide A neuritic regeneration and synaptic reconstruction – Kuboyama, Tohda, Komatsu, British Journal of Pharmacology (2005), PMID 15711595
Withania somnifera and beta-amyloid clearance via LRP – Sehgal et al., PNAS (2012), PMID 22308347
Ashwagandha root extract and serum cortisol (RCT) – Chandrasekhar et al., Indian Journal of Psychological Medicine (2012), PMID 23439798
Ashwagandha safety and evidence overview – NCCIH (NIH)
Ashwagandha constituents and clinical evidence – Examine.com

References

Ashwagandha Cycling: Why You Should Take Breaks and How to Do It

Vikram Desai — Sat, 21 Feb 2026 16:46:10 +0000

Ashwagandha is a powerful Ayurvedic herb, but it is not a “take it forever and keep increasing the dose” supplement. The most sensible way to use it is as a defined course: take it for a clear purpose, observe whether sleep, stress tolerance, strength, recovery, or vitality actually improve, then pause and reassess. That is the real value of cycling. It protects the herb’s usefulness, reduces dose creep, and keeps the practice closer to Ayurveda’s dose-aware, person-specific approach.

Why Continuous Ashwagandha Use Needs Review

Ashwagandha (Withania somnifera) is called Ashvagandha in Sanskrit, a name commonly explained through ashva (horse) and gandha (smell), referring to the characteristic odor of the root. In the Ayurvedic Pharmacopoeia of India, Ashvagandha is the dried mature root of Withania somnifera Dunal, not the leaf, and its classical profile is tikta and kaṣāya rasa, laghu guṇa, uṣṇa vīrya, and madhura vipāka. Its actions are listed as rasāyana, vāta-kapha-hara, balya, and vājīkaraṇa.

Modern supplement language often calls ashwagandha an adaptogen, meaning it is used to support the body’s response to stress. That does not make it a daily vitamin. Human trials commonly use ashwagandha for finite periods such as 6 to 12 weeks, while major safety summaries distinguish short-term use from many months or years of continuous use. The practical lesson is simple: use ashwagandha as a course, not as an indefinite habit.

What Classical Ayurveda Actually Supports

Ayurveda treats rasāyana as rejuvenative therapy aimed at supporting strength, vitality, longevity, memory, tissue quality, and resistance to disease. Classical rasāyana is not merely a capsule routine; it includes diet, conduct, digestion, purification where appropriate, formulation choice, dose, season, age, strength, constitution, and the person’s present imbalance. The right herb for one person may be too heating, too heavy, too stimulating, or simply unnecessary for another.

For ashwagandha specifically, the pharmacopoeial adult dose is given for root powder, traditionally 3–6 g, but modern extracts are not gram-for-gram equivalents of crude root powder. Root extracts, high-withanolide products, and root-plus-leaf extracts behave differently from classical root powder or classical formulations such as Ashvagandhādi Leha. A responsible cycle begins by confirming the form, dose, purpose, and safety fit before deciding how long to continue.

Why Benefits Can Fade During Long, Unreviewed Use

When people say ashwagandha “stopped working,” the problem is often not the herb alone. It may be unclear dosing, an unsuitable form, poor sleep hygiene, ongoing overtraining, unresolved anxiety triggers, digestive overload, thyroid sensitivity, medication interaction, or simply the mistake of trying to force the same effect month after month. Planned breaks help separate true benefit from habit.

1. Stress and sleep pathways need observation

Ashwagandha is associated with stress-response pathways, cortisol changes, and GABA-related activity. That is why many people use it for calmness, sleep, and pressure tolerance. But if the herb becomes something you cannot sleep without, the cycle needs review. A break lets you see whether your baseline has improved, whether the dose is still appropriate, and whether the original problem now needs a different approach.

2. Thyroid changes matter

Ashwagandha can influence thyroid markers in some people. In an 8-week clinical trial involving adults with subclinical hypothyroidism, ashwagandha root extract changed TSH, T3, and T4 compared with placebo. This may be relevant for selected people under supervision, but it is a reason for caution in anyone with hyperthyroidism, thyroid medication use, palpitations, heat intolerance, tremor, unexplained weight change, or worsening insomnia.

3. Digestive and liver signals should not be ignored

Ashwagandha can cause stomach upset, loose stools, nausea, vomiting, and drowsiness in some users. Rare liver injury cases have also been reported, usually appearing after weeks of use. Any new itching, yellowing of the eyes or skin, dark urine, pale stools, unusual fatigue, right-upper abdominal discomfort, or unexplained nausea should be treated as a stop-and-seek-care signal rather than something to push through.

Cycling Protocols That Respect Ayurveda and Safety

The following schedules are practical templates, not personal prescriptions. They are built around the fact that most human use data is short-term and that Ayurveda favors dose, timing, digestion, constitution, and purpose over permanent unsupervised use. Choose the gentlest effective plan, and do not increase the dose just because the first-week feeling becomes less noticeable.

Protocol 1: The 6–8 Week Root-Extract Course

This is the most practical approach for people using a standardized root extract for stress, sleep, recovery, or general vitality. Use the product only within its label directions and preferably under professional guidance, especially if it is standardized for withanolides. Many commonly studied root-extract regimens fall in the 300–600 mg/day range, but the correct amount depends on the product, person, and purpose.

On phase: 6–8 weeks of consistent use.
Pause: 2–4 weeks completely off ashwagandha.
Review before restarting: sleep, anxiety, digestion, heat signs, thyroid symptoms, medication changes, training load, and whether the herb is still needed.

This cycle works well when the goal is to avoid dose creep. If the benefit is clear, the dose stays stable, and there are no safety signals, the same course can be repeated after the break. If the benefit is unclear, do not restart automatically.

Protocol 2: The Seasonal 8–12 Week Course

This is closer to an Ayurvedic rhythm for people using traditional root powder, milk-based preparations, or practitioner-prescribed formulations. It gives enough time to assess strength, sleep, nourishment, recovery, and nervous-system steadiness without turning the herb into a year-round dependency.

On phase: 8–12 weeks.
Pause: about 4 weeks.
Best suited for: root powder, classical formulations, and people being guided according to constitution, digestion, season, and strength.

This approach is especially useful for people who are lean, depleted, overworked, recovering, or using ashwagandha as a nourishing rasāyana. It is not ideal for people with strong heat signs, active thyroid concerns, or a tendency toward heaviness, sluggish digestion, or congestion unless a qualified practitioner adjusts the plan.

Protocol 3: The Weekday Cycle

A weekday cycle is a lighter option for people who want support during demanding work or training days but do not want to take ashwagandha every day. It should still include a longer pause after several weeks.

On phase: Monday to Friday.
Off phase: Saturday and Sunday.
Longer review pause: take 2–4 weeks off after 8–12 weeks of this pattern.

This is not a substitute for medical supervision, and it is not a way to make high doses safe. Its main advantage is behavioral: it prevents the supplement from becoming automatic and creates a built-in check on whether the herb is still useful.

What to Do During the Off-Cycle

The off-cycle should not become a game of replacing ashwagandha with another strong supplement. The first layer is always routine: regular sleep timing, adequate food, appropriate training recovery, reduced late stimulants, breathwork, meditation, and attention to digestion. These foundations are often the difference between “ashwagandha works” and “ashwagandha is covering up a lifestyle problem.”

Goal During the Break	Ayurvedic Direction	Practical Focus
Maintain sleep quality	Calm vāta, reduce evening stimulation, support routine	Consistent bedtime, warm evening routine, fewer late screens and stimulants
Maintain stress resilience	Strengthen daily rhythm rather than adding more stimulation	Breath practice, meditation, walking, realistic workload boundaries
Maintain training recovery	Support nourishment, digestion, and rest	Protein-rich meals, adequate calories, planned rest days, less overreaching
Need herbal support	Use practitioner-selected alternatives only when appropriate	Jatamansi or Brahmi may be considered in suitable cases, but they are not automatic substitutes

The most important rule is to avoid stacking multiple calming, sedating, thyroid-active, or hormone-active products without guidance. A break is meant to simplify the system, not create a more complicated one.

Signs You Should Pause Ashwagandha Now

A pause is wise when the herb is no longer producing a clear benefit or when new symptoms appear. Do not respond to fading effects by doubling the dose. Use the following signs as a reason to stop, reassess, and seek professional advice where needed.

Dose creep: the amount that felt useful no longer feels useful, and you are tempted to keep increasing it.
Sleep changes: new insomnia, middle-of-the-night waking, excessive drowsiness, or disturbing changes in sleep quality.
Heat or thyroid-like symptoms: palpitations, tremor, heat intolerance, unexplained irritability, sweating, or unexplained weight change.
Digestive upset: nausea, loose stools, vomiting, abdominal discomfort, or loss of appetite that began after starting the product.
Liver warning signs: itching, yellow eyes or skin, dark urine, pale stools, unusual fatigue, or persistent nausea.
Medication changes: starting or changing thyroid medication, sedatives, anticonvulsants, diabetes medication, blood pressure medication, immunosuppressants, or other prescriptions.
Life-stage or procedure changes: pregnancy, trying to conceive, breastfeeding, upcoming surgery, or a new diagnosis involving the thyroid, liver, autoimmune system, or hormone-sensitive prostate disease.

How to Stop Without Turning the Break Into a Problem

Most people using a moderate, short-term root product can simply finish the course and stop for the planned break. If you have been taking high doses, combining multiple ashwagandha products, using it nightly for sleep or anxiety, or taking prescription medications, stop under professional guidance rather than making abrupt changes on your own.

During the first week off, keep the routine steady. Do not add several new supplements at once. Watch sleep, mood, digestion, heart rate, heat signs, and energy. If symptoms appear, the answer is not to restart blindly; it is to review the dose, product quality, diagnosis, medicines, and whether ashwagandha is the right herb for your current state.

Ashwagandha Forms and Cycling Considerations

Not all ashwagandha products should be treated the same. Classical Ayurveda and the pharmacopoeial standard center on the mature root. Modern supplement products may use root extract, root powder, root-plus-leaf extract, gummies, capsules, liquids, or blends with many other herbs. Cycling decisions should change according to form and potency.

Root powder: closest to the pharmacopoeial crude drug form. It is traditionally used with attention to digestion, constitution, and vehicle such as milk or ghee where appropriate.
Standardized root extract: more concentrated and easier to overuse. A 6–8 week course with a break is usually more sensible than open-ended daily use.
Root-plus-leaf or high-withanolide extracts: not the classical pharmacopoeial standard for Ashvagandha root. Ayurveda-oriented use should favor root-only products unless a qualified professional has a clear reason otherwise.
Leha, arishta, and compound formulations: these are formulation-specific and should not be treated as identical to single-herb extract capsules.
Multi-ingredient “stress” or “testosterone” blends: harder to assess because side effects or interactions may come from any ingredient in the blend.

Who Should Not Take Ashwagandha Without Medical Clearance

Ashwagandha is not appropriate for everyone. The following groups should avoid self-prescribing it and should consult a qualified healthcare provider or Ayurvedic practitioner before use.

Pregnant or breastfeeding people: avoid use unless specifically directed by a qualified clinician.
People with thyroid disorders: especially hyperthyroidism, Graves’ disease, thyroid medication use, or unstable thyroid labs.
People with autoimmune conditions: especially those using immunosuppressive therapy.
People with liver disease or elevated liver enzymes: use extra caution because liver injury has been reported.
People with hormone-sensitive prostate cancer: avoid unless cleared by the treating physician.
People taking sedatives, anticonvulsants, thyroid medicines, diabetes medicines, blood pressure medicines, or immunosuppressants: use only with medical guidance.
People preparing for surgery: stop and disclose use to the surgical team according to medical advice.

Ashwagandha remains one of Ayurveda’s valuable rasāyana herbs when used with respect for form, dose, timing, constitution, digestion, and safety. The best long-term approach is not endless escalation. It is a clear course, a planned pause, and an honest review of whether the herb is still needed.

It did not need to be forced. It needed a well-timed rest.

Disclaimer: This article is for informational purposes only and does not replace professional medical advice. Consult a qualified Ayurvedic practitioner or healthcare provider before using ashwagandha, especially if you take prescription medication, have a diagnosed medical condition, are pregnant or breastfeeding, have thyroid, liver, autoimmune, or prostate-related concerns, or are planning surgery.